Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future
Top Cited Papers
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (4) , 193-200
- https://doi.org/10.1016/j.tips.2004.02.007
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Haplotypes ofCYP3A4 and their close linkage withCYP3A5 haplotypes in a Japanese populationHuman Mutation, 2003
- Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarinThe Pharmacogenomics Journal, 2003
- Cytochrome P450 Phenotyping/Genotyping in Patients Receiving AntipsychoticsClinical Pharmacokinetics, 2002
- Clinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismClinical Pharmacokinetics, 2002
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- The pharmacogenetics of codeine hypoalgesiaPharmacogenetics, 1995
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990
- LOW FREQUENCY OF SLOW DEBRISOQUINE HYDROXYLATION IN A NATIVE CHINESE POPULATIONThe Lancet, 1987
- Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylaseBiochemistry, 1987
- Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compoundsLife Sciences, 1967